Abstract: Background: Donor-derived endemic mycoses are infrequently reported. We summarized the clinical characteristics and outcomes of these infections to provide guidance to transplant clinicians.
Methods: Multiple databases were reviewed from inception through May 31, 2023 using endemic fungi as key words (e.g., Coccidioides, histoplasma, blastomyces, talaromyces, paracoccidioides). Only donor-derived infections (DDI) were included.
Results: Twenty-four cases of DDI were identified from 18 published reports; these included 16 coccidioidomycosis, seven histoplasmosis, and one talaromycosis. No cases of blastomycosis and paracoccidiodomycosis were published. The majority were male (17/24,70.8%). Half of the cases were probable (12/24, 50%), seven were possible (29.2%), and only five were proven DDI (20.8%). Donor-derived coccidioidomycosis were observed in kidney (n = 11), lung (n = 6), liver (n = 3), heart (n = 2) and combined SOT recipients (1 KP, 1 KL) at a median time of .9 (range .2-35) months after transplantation. For histoplasmosis, the majority were kidney recipients (6 of 7 cases) at a median onset of 8 (range .4-48) months after transplantation. The single reported possible donor-derived talaromycosis occurred in a man whose organ donor had at-risk travel to Southeast Asia. Collectively, the majority of donors had high-risk exposure to Coccidioides (9/11) or Histoplasma sp. (6/6). Most donor-derived endemic mycoses were disseminated (18/24, 75%), and mortality was reported in almost half of recipients (11/24, 45.8%).
Conclusion: Donor-derived endemic mycoses are often disseminated and are associated with high mortality. A detailed evaluation of donors for the potential of an undiagnosed fungal infection prior to organ donation is essential to mitigate the risk of these devastating infections.
(© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
References: Wolfe CR, Ison MG. Donor-derived infections: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13547.
Echenique IA, Ison MG. Update on donor-derived infections in liver transplantation. Liver Transpl. 2013;19(6):575-585.
Garzoni C, Ison MG. Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation. Transplantation. 2011;92(12):1297-1300.
Malinis M, La Hoz RM, Vece G, et al. Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018. Transpl Infect Dis. 2022;24(2):e13800.
De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-1821.
Blodget E, Geiseler PJ, Larsen RA, Stapfer M, Qazi Y, Petrovic LM. Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients. Transpl Infect Dis. 2012;14(3):305-310.
Brugière O, Forget E, Biondi G, et al. Coccidioidomycosis in a lung transplant recipient acquired from the donor graft in France. Transplantation. 2009;88(11):1319-1320.
Carvalho C, Ferreira I, Gaiao S, et al. Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transpl Infect Dis. 2010;12(2):151-154.
Dierberg KL, Marr KA, Subramanian A, et al. Donor-derived organ transplant transmission of coccidioidomycosis. Transpl Infect Dis. 2012;14(3):300-304.
Dossetor JB, Gault MH, Oliver JA, Inglis FG, Mackinnon KJ, Maclean LD. Cadaver renal homotransplants: initial experiences. Can Med Assoc J. 1964;91:733-742.
Hermans F, Ombelet S, Degezelle K, et al. First-in-man observation of Talaromyces marneffei-transmission by organ transplantation. Mycoses. 2017;60(3):213-217.
Hood AB, Inglis FG, Lowenstein L, Dossetor JB, MacLean LD. Histoplasmosis and thrombocytopenic purpura: transmission by renal homotransplantation. Can Med Assoc J. 1965;93(11):587-592.
Limaye AP, Connolly PA, Sagar M, et al. Transmission of histoplasma capsulatum by organ transplantation. N Engl J Med. 2000;343(16):1163-1166.
McAninch EA, Xu C, Lagari VS, Kim BW. Coccidiomycosis thyroiditis in an immunocompromised host post-transplant: case report and literature review. J Clin Endocrinol Metab. 2014;99(5):1537-1542.
Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol. 2004;42(5):2347-2349.
Nelson JK, Giraldeau G, Montoya JG, Deresinski S, Ho DY, Pham M. Donor-derived Coccidioides immitis endocarditis and disseminated infection in the setting of solid organ transplantation. Open Forum Infect Dis. 2016;3(3):ofw086.
Shah SS, Karnak D, Shah SN, et al. Broncholith caused by donor-acquired histoplasmosis in a lung transplant recipient. J Heart Lung Transplant. 2007;26(4):407-410.
Singh G, Patel T, Hu S. Disseminated cutaneous coccidioidomycosis in a liver transplant patient. JAAD Case Rep. 2015;1(4):225-226.
Tepeoglu M, Erinanc H, Ozdemir H, Turan H, Moray G, Haberal M. Pulmonary coccidioidomycosis after a renal transplant in a nonendemic region. Exp Clin Transplant. 2014;12(1):71-73.
Tripathy U, Yung GL, Kriett JM, Thistlethwaite PA, Kapelanski DP, Jamieson SW. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg. 2002;73(1):306-308.
Watanabe M, Hotchi M, Nagasaki M. An autopsy case of disseminated histoplasmosis probably due to infection from a renal allograft. Acta Pathol Jpn. 1988;38(6):769-780.
Wong SY, Allen DM. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: case report. Clin Infect Dis. 1992;14(1):232-234.
Wright PW, Pappagianis D, Wilson M, et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis. 2003;37(9):1265-1269.
Kusne S, Taranto S, Covington S, et al. Coccidioidomycosis transmission through organ transplantation: a report of the OPTN Ad Hoc Disease Transmission Advisory Committee. Am J Transplant. 2016;16(12):3562-3567.
Miller R, Assi M. Endemic fungal infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13553.
Agarwal M, Nokes B, Blair JE. Coccidioidomycosis and solid organ transplantation. Curr Fungal Infect Rep. 2021;15(4):143-150.
Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112-e146.
Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33(9):1536-1544.
Wheat LJ, Smith EJ, Sathapatayavongs B, et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Intern Med. 1983;143(4):703-707.
Abad CLR, Bhaimia E, Schuetz AN, Razonable RR. A comprehensive review of Strongyloides stercoralis infection after solid organ and hematopoietic stem cell transplantation. Clin Transplant. 2022;36(11):e14795.
Abad CLR, Razonable RR. Mycobacterium tuberculosis after solid organ transplantation: a review of more than 2000 cases. Clin Transplant. 2018;32(6):e13259.
No Comments.